The store will not work correctly when cookies are disabled.
5-Difluoromethyl-1-(3-fluoro-4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-1H-pyrimidine-2,4-dione
ID: ALA2368781
PubChem CID: 15608759
Max Phase: Preclinical
Molecular Formula: C10H11F3N2O5
Molecular Weight: 296.20
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=c1[nH]c(=O)n([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2F)cc1C(F)F
Standard InChI: InChI=1S/C10H11F3N2O5/c11-5-6(17)4(2-16)20-9(5)15-1-3(7(12)13)8(18)14-10(15)19/h1,4-7,9,16-17H,2H2,(H,14,18,19)/t4-,5+,6-,9-/m1/s1
Standard InChI Key: JURCDKOMRODTHK-FMDIHHLLSA-N
Molfile:
RDKit 2D
20 21 0 0 1 0 0 0 0 0999 V2000
9.2154 -1.4764 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.2154 -2.3014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9299 -1.0639 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9299 -0.2389 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.5010 -0.2389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5010 -1.0639 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2154 0.1736 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8829 -2.7863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5480 -2.7863 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.6279 -3.5709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8029 -3.5709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7865 0.1736 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6444 -1.4764 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.2154 0.9986 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.6675 -2.5314 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
10.1129 -4.2384 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.7865 0.9986 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
7.0720 -0.2389 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
8.3180 -4.2384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6536 -4.9921 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 1
3 1 1 0
4 3 1 0
5 6 2 0
6 1 1 0
7 5 1 0
2 8 1 0
9 2 1 0
10 8 1 0
11 9 1 0
12 5 1 0
13 3 2 0
14 7 2 0
8 15 1 1
10 16 1 6
17 12 1 0
18 12 1 0
11 19 1 1
20 19 1 0
4 7 1 0
11 10 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 296.20 | Molecular Weight (Monoisotopic): 296.0620 | AlogP: -0.94 | #Rotatable Bonds: 3 |
Polar Surface Area: 104.55 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.94 | CX Basic pKa: ┄ | CX LogP: -1.25 | CX LogD: -1.27 |
Aromatic Rings: 1 | Heavy Atoms: 20 | QED Weighted: 0.67 | Np Likeness Score: 0.32 |
References
1. Matulic-Adamic J, Takahashi K, Chou TC, Gadler H, Price RW, Reddy AR, Kalman TI, Watanabe KA.. (1988) Nucleosides. 150. Synthesis and some biological properties of 5-monofluoromethyl, 5-difluoromethyl, and 5-trifluoromethyl derivatives of 2'-deoxyuridine and 2'-deoxy-2'-fluoro-beta-D-arabinofuranosyluracil., 31 (8): [PMID:2840503] [10.1021/jm00403a026] |